Navigation Links
Glycerin Proven to Improve Bruising and Swelling Caused By Trauma to Skin

Study Findings Confirm Glycerin Accelerates the Healing Process

in Damaged Tissue and Cells

MANDEVILLE, La., May 15 /PRNewswire/ -- Today, a leading expert in the field of non-surgical skin rejuvenation announced results from a study demonstrating that glycerin helps to speed up the healing process of damaged tissue and cells, resulting in less bruising and skin discoloration.

In a double-blinded, placebo-controlled clinical study of a glycerin-based bruise-reaction product, 65 percent of the patients who experienced bruising after filler injection procedures saw a reduction in the severity and duration of bruising with a single post-procedural application of Bruise Relief(TM) serum versus a placebo. The product was found to reduce the appearance of bruising with no reported side effects.

"Glycerin, as an active ingredient in Bruise Relief(TM), helps with the rejuvenation process of the skin," said Dr. Mary P. Lupo, dermatologist and non-surgical skin rejuvenation expert. "The most common treatment-related complication from filler injections is bruising. I have seen a significant decrease in bruising after treatments with an application of Bruise Relief(TM). Post-procedural Botox and leg vein injections (sclerotherapy) may also benefit from this single post-procedural application."

Glycerin, a humectant, attracts water and helps lubricate and hydrate the skin's cells. It is a thick, water-soluble liquid. Bruises occur when capillary blood vessels break and blood and fluids pool underneath the skin. Glycerin's hydrating properties enable the body to seal off the broken capillaries and blood vessels caused by trauma to the skin and help prevent the pooling of blood and fluids.

Bruise Relief(TM), available in a gel or serum formulation, also contains vitamins, nutrients and antioxidants and is non-toxic and safe for all ages and skin types. Bruise Relief (TM) gel is available nationwide at all CVS stores as well as at Jewel/Osco, Albertsons, Acme, Shaw's and other fine pharmacies across the country.

"Bruise Relief(TM) has been in my family for nearly five generations," said Barbara Cranner, executive vice president of Dr. Holmquist Healthcare, LLC. "We developed the product for the mass market with my stepfather, Dr. Nelson Holmquist, and we are thrilled to share an old family recipe with the world."

About Dr. Holmquist Healthcare, LLC

Dr. Holmquist Healthcare, LLC is a family- and majority-woman-owned and operated company. Headquartered in Mandeville, Louisiana, the company is dedicated to the revitalization of New Orleans, and manufactures the company's product lines at local plants. Dr. Holmquist Healthcare's product line currently features Bruise Relief(TM), a topical skin care product in a gel and serum formulation designed to eliminate the appearance of bruising and skin discoloration. Learn more about Dr. Holmquist Healthcare and its products at

CONTACT: Holly Campbell, Levick Strategic Communications, +1-202-973-1337,

SOURCE Dr. Holmquist Healthcare, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
2. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
3. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
4. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
5. Derma Sciences MEDIHONEY(TM) Proven to Speed Healing in Stalled Leg Ulcers
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
8. Clinically Proven Treatment Offers Help to Rosacea Sufferers
9. Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term
10. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
11. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
Post Your Comments:
(Date:12/1/2015)... BOSTON , Dec. 1, 2015  Six months of ... adolescents with type 1 diabetes, according to new research from ... . However, it may have a beneficial effect on measures ... the current issue of the Journal of the American ... date examining the effect of metformin on overweight and obese ...
(Date:12/1/2015)... Russia has always been a ... new drugs registered in Europe in 2015 were ... Russia has always been a country of choice ... in Europe in 2015 were tested in phase ... Russia has always been a country of choice for global ...
(Date:12/1/2015)... 1, 2015 Contraceptives ... Contraceptives, Male Condoms, Female Condoms, Intrauterine Devices, ... Diaphragms, Contraceptive Sponges, Non-Surgical Permanent Contraception Devices) ... Trends and Forecast 2014 - 2020 ", ... (TMR).The report states that the global contraceptives ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... The workstation boundaries ... as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable DICOM-calibrated medical ... November 29 to December 4, 2015. , MED-TAB is expected to change ...
(Date:12/1/2015)... ... 01, 2015 , ... The importance of volumetric breast density ... of numerous abstracts accepted for presentation here, at the 101st Annual Radiology Society ... the use of Volpara Solutions’ quantitative breast imaging software tools for providing breast ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the millions of people ... Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic intermittent catheter. “Hollister ... free catheter portfolio,” said Michael Gresavage, Vice President North America. "We designed our ...
(Date:12/1/2015)... ... 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, 2015) ... has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) service ... special needs providers that excel in synthesizing the areas of clinical quality, staff ...
(Date:12/1/2015)... ... December 01, 2015 , ... McLean, ... been awarded a fixed price per sprint agile development contract to support the ... million over five years, provides software engineering, infrastructure, as well as operations and ...
Breaking Medicine News(10 mins):